154 related articles for article (PubMed ID: 31220051)
21. Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care.
Ward MM; Leigh JP; Fries JF
Arch Intern Med; 1993 Oct; 153(19):2229-37. PubMed ID: 8215726
[TBL] [Abstract][Full Text] [Related]
22. Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.
Castrejon I; Shakoor N; Chua JR; Block JA
Rheumatol Int; 2018 Nov; 38(11):2137-2145. PubMed ID: 30293155
[TBL] [Abstract][Full Text] [Related]
23. Eligibility of rheumatoid arthritis patients for anti-TNF-alpha therapy according to the 2005 recommendations of the French and British Societies for Rheumatology.
Fautrel B; Flipo RM; Saraux A
Rheumatology (Oxford); 2008 Nov; 47(11):1698-703. PubMed ID: 18794185
[TBL] [Abstract][Full Text] [Related]
24. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
Pincus T; Swearingen CJ; Bergman M; Yazici Y
J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
[TBL] [Abstract][Full Text] [Related]
25. Survey on management strategies of rheumatoid arthritis in Saudi Arabia: a Saudi Society for Rheumatology Initiative.
Omair MA; Omair MA; Halabi H
Int J Rheum Dis; 2017 Sep; 20(9):1185-1192. PubMed ID: 26354409
[TBL] [Abstract][Full Text] [Related]
26. Average time taken by a Rheumatology patient to reach a Rheumatologist in Pakistan.
Saif S; Kithlew R
J Pak Med Assoc; 2022 Nov; 72(11):2204-2208. PubMed ID: 37013287
[TBL] [Abstract][Full Text] [Related]
27. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
Pope JE; Hong P; Koehler BE
J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
[TBL] [Abstract][Full Text] [Related]
28. MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites.
El-Haddad C; Castrejon I; Gibson KA; Yazici Y; Bergman MJ; Pincus T
RMD Open; 2017; 3(1):e000391. PubMed ID: 29225915
[TBL] [Abstract][Full Text] [Related]
29. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
30. Delays between the onset of symptoms and first rheumatology consultation in patients with rheumatoid arthritis in the UK: an observational study.
Stack RJ; Nightingale P; Jinks C; Shaw K; Herron-Marx S; Horne R; Deighton C; Kiely P; Mallen C; Raza K;
BMJ Open; 2019 Mar; 9(3):e024361. PubMed ID: 30837252
[TBL] [Abstract][Full Text] [Related]
31. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
[TBL] [Abstract][Full Text] [Related]
32. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
Pincus T; Yazici Y; Bergman MJ
Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
[TBL] [Abstract][Full Text] [Related]
33. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.
Katchamart W; Narongroeknawin P; Chevaisrakul P; Dechanuwong P; Mahakkanukrauh A; Kasitanon N; Pakchotanon R; Sumethkul K; Ueareewongsa P; Ukritchon S; Bhurihirun T; Duangkum K; Intapiboon P; Intongkam S; Jangsombatsiri W; Jatuworapruk K; Kositpesat N; Leungroongroj P; Lomarat W; Petcharat C; Sittivutworapant S; Suebmee P; Tantayakom P; Tipsing W; Asavatanabodee P; Chiowchanwisawakit P; Foocharoen C; Koolvisoot A; Louthrenoo W; Siripaitoon B; Totemchokchyakarn K; Kitumnuaypong T;
Int J Rheum Dis; 2017 Sep; 20(9):1142-1165. PubMed ID: 27452207
[TBL] [Abstract][Full Text] [Related]
34. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
Gerber LH; Furst G; Yarboro C; el-Gabalawy H
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
[TBL] [Abstract][Full Text] [Related]
35. The incidence rate and the early management of rheumatoid arthritis in Slovenia.
Ješe R; Perdan-Pirkmajer K; Hočevar A; Rotar Ž; Markez S; Pavič-Nikolič M; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):273-278. PubMed ID: 30073459
[TBL] [Abstract][Full Text] [Related]
36. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.
Hernández-García C; Vargas E; Abásolo L; Lajas C; Bellajdell B; Morado IC; Macarrón P; Pato E; Fernández-Gutiérrez B; Bañares A; Jover JA
J Rheumatol; 2000 Oct; 27(10):2323-8. PubMed ID: 11036824
[TBL] [Abstract][Full Text] [Related]
37. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
38. Patient's ethnicity does not influence utilization of effective therapies in rheumatoid arthritis.
Ang DC; Paulus HE; Louie JS
J Rheumatol; 2006 May; 33(5):870-8. PubMed ID: 16652419
[TBL] [Abstract][Full Text] [Related]
39. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
40. Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis.
Kalkan A; Hallert E; Carlsson P; Roback K; Sjöwall C
Scand J Rheumatol; 2015; 44(4):265-70. PubMed ID: 26202443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
